<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mature B-cell differentiation provides an important mechanism for the acquisition of adaptive immunity </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">Malignancies</z:e> derived from mature B cells constitute the majority of <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>These <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> often maintain the characteristics of the <z:mpath ids='MPATH_458'>normal</z:mpath> B cells that they are derived from, a feature that is frequently used in their diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>The role of microRNAs in mature B cells is largely unknown </plain></SENT>
<SENT sid="4" pm="."><plain>Through concomitant microRNA and <z:chebi fb="2" ids="33699">mRNA</z:chebi> profiling, we demonstrate a potential regulatory role for microRNAs at every stage of the mature B-cell differentiation process </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, we have experimentally identified a direct role for the microRNA regulation of key transcription factors in B-cell differentiation: LMO2 and PRDM1 (Blimp1) </plain></SENT>
<SENT sid="6" pm="."><plain>We also profiled the microRNA of B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> derived from diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>We found that, in contrast to many other <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, common B-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> do not down-regulate microRNA expression </plain></SENT>
<SENT sid="8" pm="."><plain>Although these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> could be distinguished from each other with use of microRNA expression, each <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> type maintained the expression of the lineage-specific microRNAs </plain></SENT>
<SENT sid="9" pm="."><plain>Expression of these lineage-specific microRNAs could correctly predict the lineage of B-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> in more than 95% of the cases </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, our data demonstrate that microRNAs may be important in maintaining the mature B-<z:mp ids='MP_0005384'>cell phenotype</z:mp> in <z:mpath ids='MPATH_458'>normal</z:mpath> and malignant B cells </plain></SENT>
</text></document>